Clinical trials which charge patients four- to six-figure enrollment fees may be on the rise — and they've caught the attention of the FDA and NIH. My ⁦⁩ story
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny via
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny.
Amid rising concern, pay-to-play clinical trials requiring patients to pay $7,000 to $25,000 to enroll are drawing federal scrutiny from the FDA
Pay to participate in clinical trials? By via
If you read my story this summer on pay-to-play clinical trials (), you may be interested in a new JAMA viewpoint article on the subject from two of the bioethicists I quoted.
Amid rising concern, pay-to-play clinical trials are drawing US federal scrutiny via
Great article by I suggest these companies think they found a loophole in FDA drug marketing regulations, and perhaps they have. I'm hopeful the FDA will stomp this out quickly before it spreads further.
Shout-out to for this smart, illuminating illustration of a fraught and abstract topic
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny: NO TO PAY TO PLAY
That rare moment in which & I disagree, at least at the margins, about the permissibility of pay-to-play clinical trials. From .
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny via
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny
When is it OK for someone to pay to be in a clinical trial and when isn't it?
If anyone can write a great, attention-grabbing lede about IRBs, it's